NEW AGE FOR NUCLEAR MEDICINE
Radioactive drugs are not just diagnosing disease more effectively, they’re now being used for exciting new therapies. They could be revolutionary in fighting cancer in the 21st century, says Sandy McEwan, vice president of radiopharmaceuticals at Ipsen.
Recent News
Spotlight on Neuroendocrine Cancer: Campaign Update and Healthcare Professionals’ Series Overview
The ‘Spotlight on Neuroendocrine Cancer’ campaign aims to raise awareness of neuroendocrine cancer among non-neuroendocrine cancer specialist healthcare professionals. The campaign collaborates with the UK and Ireland Neuroendocrine Tumour Society (UKINETS). To enable...
Research Trial – LANTana: RECRUITING
SELECT HERE TO DOWNLOAD
New Research Trial – The NELMAS trial
NELMAS - An international multi-centre, stratified, open, randomized, comparator-controlled, parallel-group phase II study comparing adjuvant treatment with 177Lu-DOTATATE (Lutathera®) to best supportive care in patients after resection of neuroendocrine liver...